This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Dr Li has over 20 years of research experience in neuroscience. He has a Ph.D. degree as well as postdoctoral training in this field. He became interested in Transcranial Magnetic Stimulation (Deep TMS) therapy study as early as in 2001 when he was a resident and instructor at Harvard Medical school.
Please fill all the marked fields